Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
Manufactures cancer drugs, vaccines, and medical devices across China and globally
16.33+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-13.3%
The outlook
Analysts collectively lean bullish on 2196.HK, with an average price target implying roughly 71% upside from current levels. However, the stock is trading well below both its 50- and 200-day moving averages and sits near the lower end of its 52-week range, reflecting recent weakness. The overall sentiment remains neutral as the price trend conflicts with analyst optimism.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 6 analysts
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +71% vs current price
Analyst price target
~12-month · 6 analysts27.93average target+71.0% vs now
Now 16.33
Low 18.38High 35.31
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$43.61B
52-wk high
29.00
52-wk low
14.90
50-day avg
16.44
200-day avg
19.70
Trailing P/E
10.7